CME Group Inc.
BG ˙ BUL ˙ US12572Q1058
SecurityBG:MX4A / CME Group Inc.
InstitutionSageView Advisory Group, LLC
Latest Disclosed Ownership9,038 shares
Latest Disclosed Value $ 2,468,095
SageView Advisory Group, LLC reports 17.99% decrease in ownership of MX4A / CME Group Inc.

On February 17, 2026 - SageView Advisory Group, LLC filed a 13F-HR form disclosing ownership of 9,038 shares of CME Group Inc. (BG:MX4A) valued at $2,468,095 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 11,020 shares of CME Group Inc.. This represents a change in shares of -17.99% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F CME GROUP COM 12572Q105 9,038 -1,982 -17.99 2,468 -17.10 0.0834
2025-11-13 2025-09-30 13F CME GROUP COM 12572Q105 11,020 6,866 165.29 2,977 161.60 0.1027
2025-08-13 2025-06-30 13F CME GROUP COM 12572Q105 4,154 19 0.46 1,139 3.83 0.0431
2025-05-19 2025-03-31 13F CME GROUP COM 12572Q105 4,135 -1,031 -19.96 1,097 -8.59 0.0468
2025-02-13 2024-12-31 13F CME GROUP COM 12572Q105 5,166 2,153 71.46 1,200 80.57 0.0516
2024-11-14 2024-09-30 13F CME GROUP COM 12572Q105 3,013 -964 -24.24 665 -14.98 0.0337
2024-08-15 2024-06-30 13F/A-1 CME GROUP COM 12572Q105 3,977 945 31.17 782 19.79 0.0363
2024-08-12 2024-06-30 13F CME GROUP COM 12572Q105 3,032 0 653 0.0295
2024-05-09 2024-03-31 13F CME GROUP COM 12572Q105 3,032 -856 -22.02 653 -18.60 0.0330
2024-03-06 2023-12-31 13F/A-2 CME GROUP COM 12572Q105 3,888 910 30.56 801 34.40 0.0345
2024-02-16 2023-12-31 13F/A-1 CME GROUP COM 12572Q105 3,888 910 801 0.0342
2024-02-09 2023-12-31 13F CME GROUP COM 12572Q105 3,888 910 801 0.0342
2023-11-03 2023-09-30 13F CME GROUP COM 12572Q105 2,978 -57 -1.88 596 6.05 0.0342
2023-08-11 2023-06-30 13F CME GROUP COM 12572Q105 3,035 -2,532 -45.48 562 -47.28 0.0313
2023-05-02 2023-03-31 13F CME GROUP COM 12572Q105 5,567 5,567 1,066 0.0680
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.